Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michal Neeman is active.

Publication


Featured researches published by Michal Neeman.


Nature | 1998

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.

Peter Carmeliet; Yuval Dor; Jean-Marc Herbert; Dai Fukumura; Koen Brusselmans; Mieke Dewerchin; Michal Neeman; Françoise Bono; Rinat Abramovitch; Patrick H. Maxwell; Cameron J. Koch; Peter J. Ratcliffe; Lieve Moons; Rakesh K. Jain; Desire Collen; Eli Keshet

As a result of deprivation of oxygen (hypoxia) and nutrients, the growth and viability of cells is reduced. Hypoxia-inducible factor(HIF)-1α helps to restore oxygen homeostasis by inducing glycolysis, erythropoiesis and angiogenesis. Here we show that hypoxia and hypoglycaemia reduce proliferation and increase apoptosis in wild-type (HIF-1α+/+) embryonic stem (ES) cells, but not in ES cells with inactivated HIF-1α genes (HIF-1α−/−); however, a deficiency of HIF-1α does not affect apoptosis induced by cytokines. We find that hypoxia/hypoglycaemia-regulated genes involved in controlling the cell cycle are either HIF-1α-dependent (those encoding the proteins p53, p21, Bcl-2) or HIF-1α-independent (p27, GADD153), suggesting that there are at least two different adaptive responses to being deprived of oxygen and nutrients. Loss of HIF-1α reduces hypoxia-induced expression of vascular endothelial growth factor, prevents formation of large vessels in ES-derived tumours, and impairs vascular function, resulting in hypoxic microenvironments within the tumour mass. However, growth of HIF-1α tumours was not retarded but was accelerated, owing to decreased hypoxia-induced apoptosis and increased stress-induced proliferation. As hypoxic stress contributes to many (patho)biological disorders,, this new role for HIF-1α in hypoxic control of cell growth and death may be of general pathophysiological importance.


Journal of Clinical Investigation | 2008

Uterine DCs are crucial for decidua formation during embryo implantation in mice

Vicki Plaks; Tal Birnberg; Tamara Berkutzki; Shay Sela; Adi BenYashar; Vyacheslav Kalchenko; Gil Mor; Eli Keshet; Nava Dekel; Michal Neeman; Steffen Jung

Implantation is a key stage during pregnancy, as the fate of the embryo is often decided upon its first contact with the maternal endometrium. Around this time, DCs accumulate in the uterus; however, their role in pregnancy and, more specifically, implantation, remains unknown. We investigated the function of uterine DCs (uDCs) during implantation using a transgenic mouse model that allows conditional ablation of uDCs in a spatially and temporally regulated manner. Depletion of uDCs resulted in a severe impairment of the implantation process, leading to embryo resorption. Depletion of uDCs also caused embryo resorption in syngeneic and T cell-deficient pregnancies, which argues against a failure to establish immunological tolerance during implantation. Moreover, even in the absence of embryos, experimentally induced deciduae failed to adequately form. Implantation failure was associated with impaired decidual proliferation and differentiation. Dynamic contrast-enhanced MRI revealed perturbed angiogenesis characterized by reduced vascular expansion and attenuated maturation. We suggest therefore that uDCs directly fine-tune decidual angiogenesis by providing two critical factors, sFlt1 and TGF-beta1, that promote coordinated blood vessel maturation. Collectively, uDCs appear to govern uterine receptivity, independent of their predicted role in immunological tolerance, by regulating tissue remodeling and angiogenesis. Importantly, our results may aid in understanding the limited implantation success of embryos transferred following in vitro fertilization.


The Lancet | 2000

Autoimmune T cells as potential neuroprotective therapy for spinal cord injury

Ehud Hauben; Uri Nevo; Eti Yoles; Gila Moalem; Eugenia Agranov; Felix Mor; Solange Akselrod; Michal Neeman; Irun R. Cohen; Michal Schwartz

Autoimmune T cells against central nervous system myelin associated peptide reduce the spread of damage and promote recovery in injured rat spinal cord, findings that might lead to neuroprotective cell therapy without risk of autoimmune disease.


Nature Medicine | 2003

Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI

Shimon Gross; Assaf Gilead; Avigdor Scherz; Michal Neeman; Yoram Salomon

Antivascular photodynamic therapy (PDT) of tumors with palladium-bacteriopheophorbide (TOOKAD) relies on in situ photosensitization of the circulating drug by local generation of cytotoxic reactive oxygen species, which leads to rapid vascular occlusion, stasis, necrosis and tumor eradication. Intravascular production of reactive oxygen species is associated with photoconsumption of O2 and consequent evolution of paramagnetic deoxyhemoglobin. In this study we evaluate the use of blood oxygenation level–dependent (BOLD) contrast magnetic resonance imaging (MRI) for real-time monitoring of PDT efficacy. Using a solid tumor model, we show that TOOKAD-PDT generates appreciable attenuation (25–40%) of the magnetic resonance signal, solely at the illuminated tumor site. This phenomenon is independent of, though augmented by, ensuing changes in blood flow. These results were validated by immunohistochemistry and intravital microscopy. The concept of photosensitized BOLD-contrast MRI may have intraoperative applications in interactive guidance and monitoring of antivascular cancer therapy, PDT treatment of macular degeneration, interventional cardiology and possibly other biomedical disciplines.


Nature Medicine | 2007

MRI detection of transcriptional regulation of gene expression in transgenic mice.

Batya Cohen; Keren Ziv; Vicki Plaks; Tomer Israely; Vyacheslav Kalchenko; Alon Harmelin; Laura E. Benjamin; Michal Neeman

Ferritin, the iron storage protein, was recently suggested to be a candidate reporter for the detection of gene expression by magnetic resonance imaging (MRI). Here we report the generation of TET:EGFP-HAferritin (tet-hfer) transgenic mice, in which tissue-specific inducible transcriptional regulation of expression of the heavy chain of ferritin could be detected in vivo by MRI. We show organ specificity by mating the tet-hfer mice with transgenic mice expressing tetracycline transactivator (tTA) in liver hepatocytes and in vascular endothelial cells. Tetracycline-regulated overexpression of ferritin resulted in specific alterations of the transverse relaxation rate (R2) of water. Transgene-dependent changes in R2 were detectable by MRI in adult mice, and we also found fetal developmental induction of transgene expression in utero. Thus, the tet-hfer MRI reporter mice provide a new transgenic mouse platform for in vivo molecular imaging of reporter gene expression by MRI during both embryonic and adult life.


Nature Cell Biology | 2015

ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation

Gabriele D'Uva; Alla Aharonov; Mattia Lauriola; David Kain; Yfat Yahalom-Ronen; Sílvia Carvalho; Karen Weisinger; Elad Bassat; Dana Rajchman; Oren Yifa; Marina Lysenko; Tal Konfino; Julius Hegesh; Ori Brenner; Michal Neeman; Yosef Yarden; Jonathan Leor; Rachel Sarig; Richard P. Harvey; Eldad Tzahor

The murine neonatal heart can regenerate after injury through cardiomyocyte (CM) proliferation, although this capacity markedly diminishes after the first week of life. Neuregulin-1 (NRG1) administration has been proposed as a strategy to promote cardiac regeneration. Here, using loss- and gain-of-function genetic tools, we explore the role of the NRG1 co-receptor ERBB2 in cardiac regeneration. NRG1-induced CM proliferation diminished one week after birth owing to a reduction in ERBB2 expression. CM-specific Erbb2 knockout revealed that ERBB2 is required for CM proliferation at embryonic/neonatal stages. Induction of a constitutively active ERBB2 (caERBB2) in neonatal, juvenile and adult CMs resulted in cardiomegaly, characterized by extensive CM hypertrophy, dedifferentiation and proliferation, differentially mediated by ERK, AKT and GSK3β/β-catenin signalling pathways. Transient induction of caERBB2 following myocardial infarction triggered CM dedifferentiation and proliferation followed by redifferentiation and regeneration. Thus, ERBB2 is both necessary for CM proliferation and sufficient to reactivate postnatal CM proliferative and regenerative potentials.


British Journal of Cancer | 1999

Stimulation of tumour growth by wound-derived growth factors.

Rinat Abramovitch; Moshe Marikovsky; Gila Meir; Michal Neeman

SummaryThe goal of this work was to determine the molecular basis for the induction of tumour vascularization and progression by injury. Magnetic resonance imaging (MRI) studies demonstrated that administration of wound fluid derived from cutaneous injuries in pigs reduced the lag for vascularization and initiation of growth of C6 glioma spheroids, implanted in nude mice, and accelerated tumour doubling time. The former effect can be attributed to the angiogenic capacity of wound fluid as detected in vivo by MRI, and in vitro in promoting endothelial cell proliferation. The latter effect, namely the induced rate of tumour growth, is consistent with the angiogenic activity of wound fluid as well as with the finding that wound fluid was directly mitogenic to the tumour cells, and accelerated growth of C6 glioma in spheroid culture. Of the multiple growth factors present in wound fluid, two key factors, heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) and platelet-derived growth factor (PDGF), were identified as the dominant mitogens for C6 glioma, and inhibition of their activity using specific neutralizing antibodies suppressed the mitogenic effect of wound fluid on DNA synthesis in C6 glioma. This study suggests that the stimulatory effect of injury on tumour progression can possibly be attenuated by therapeutic targeting directed against a limited number of specific growth factors.


Magnetic Resonance in Medicine | 2001

Diffusion anisotropy MRI for quantitative assessment of recovery in injured rat spinal cord.

Uri Nevo; Ehud Hauben; Eti Yoles; Eugenia Agranov; Solange Akselrod; Michal Schwartz; Michal Neeman

Spinal cord injury and its devastating consequences are the subject of intensive research aimed at reversing or at least minimizing functional loss. Research efforts focus on either attenuating the post‐injury spread of damage (secondary degeneration) or inducing some regeneration. In most of these studies, as well as in clinical situations, evaluation of the state of the injured spinal cord poses a serious difficulty. To address this problem, we carried out a diffusion‐weighted MRI experiment and developed an objective routine for quantifying anisotropy in injured rat spinal cords. Rats were subjected to a contusive injury of the spinal cord caused by a controlled weight drop. Untreated control rats were compared with rats treated with T cells specific to the central nervous system self‐antigen myelin basic protein, a form of therapy recently shown to be neuroprotective. After the rats were killed their excised spinal cords were fixed in formalin and imaged by multislice spin echo MRI, using two orthogonal diffusion gradients. Apparent diffusion coefficient (ADC) values and anisotropy ratio (AI) maps were extracted on a pixel‐by‐pixel basis. The calculated sum of AI values (SAI) for each slice was defined as a parameter representing the total amount of anisotropy. The mean‐AI and SAI values increased gradually with the distance from the site of the lesion. At the site itself, the mean‐AI and SAI values were significantly higher in the spinal cords of the treated animals than in the controls (P = 0.047, P = 0.028, respectively). These values were consistent with the score of functional locomotion. The difference was also manifested in the AI maps, which revealed well‐organized neural structure in the treated rats but not in the controls. The SAI values, AI histograms, and AI maps proved to be useful parameters for quantifying injury and recovery in an injured spinal cord. These results encourage the development of diffusion anisotropy MRI as a helpful approach for quantifying the extent of secondary degeneration and measuring recovery after spinal cord injury. Magn Reson Med 45:1–9, 2001.


Academic Radiology | 2000

In vivo monitoring of tumor angiogenesis with MR imaging

Robert C. Brasch; King C.P. Li; Janet E. Husband; Mary T. Keogan; Michal Neeman; Anwar R. Padhani; David M. Shames; Karl Turetschek

Magnetic resonance (MR) imaging is a widely employed diagnostic method for the evaluation of patients with tumors. This method is noted for its remarkable soft-tissue definition, absence of ionizing radiation, high spatial and temporal resolution, and ability to generate images in any plane of the entire body. Equipment costs and, thus, examination costs are relatively high, however. MR imaging has been proposed and tested, both experimentally and clinically, as a method to characterize tumors regarding their state of angiogenesis. Multiple approaches to the challenge of MR imaging assays of angiogenesis have been proposed, some of which are potentially additive; all are intended to provide information regarding tumor microvessels. The quantitative end points that are sought include tissue plasma/blood volume, transendothelial permeability to water or solutes, perfusion/flow, and relative concentration of angiogenesis-specific molecules. The available approaches can be divided into intrinsic (non-contrast material enhanced) and contrast material-enhanced methods. The latter methods can be further divided by the type of contrast medium employed: small molecular agents that distribute rapidly in the extracellular space (so-called nonspecific or extracellular-fluid-space [ECF] agents), large molecular agents designed for prolonged intravascular retention (socalled macromolecular contrast media [MMCM] or bloodpool agents), and targeted agents intended to accumulate at the sites of concentrated angiogenesis mediator. Today, ECF contrast agents are commercially available and being used in clinical evaluations of antiangiogenesis drug treatments. Macromolecular contrast media are currently in clinical trials, but they are not now approved for use in humans. Molecular-targeted contrast media are in preclinical development. This section summarizes some of the many reports dealing with MR imaging assays of angiogenesis. For clarity, the discussion is divided by the specific MR imaging approach used. The rationale for that approach, limited information regarding the technique itself, accumulated experience, and limitations are provided, as well.


International Journal of Experimental Pathology | 2003

Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle

Michal Neeman; Rinat Abramovitch; Yael S. Schiffenbauer; Catherine Tempel

The preovulatory follicle provides a unique physiological example of rapid growth accompanied by neovascularization, two processes that are generally characteristic of pathologies such as wound repair or malignancy. During the hours preceding ovulation, follicular growth is accompanied by elevated levels of messenger RNA for vascular endothelial growth factor (VEGF). Angiogenic activity, mediated by VEGF, is manifested in the peripheral blood vessels surrounding the follicle, that show capillary sprouting and increased vascular permeability. Following ovulation, rapid infiltration of capillaries through the follicular wall is essential for the formation of the corpus luteum. In this review we compare the preovulatory follicle with a popular model of avascular solid tumour growth, namely the multicellular tumour spheroid, in particular the role of hypoxic stress in the regulation of angiogenesis in both systems.

Collaboration


Dive into the Michal Neeman's collaboration.

Top Co-Authors

Avatar

Alon Harmelin

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Hagit Dafni

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Rinat Abramovitch

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Gila Meir

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Katrien Vandoorne

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Batya Cohen

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Yoseph Addadi

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Vicki Plaks

University of California

View shared research outputs
Top Co-Authors

Avatar

Reut Avni

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Tal Raz

Hebrew University of Jerusalem

View shared research outputs
Researchain Logo
Decentralizing Knowledge